Literature DB >> 32104975

A Cerberus-Inspired Anti-Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging "Superbug" Yeast Candida auris.

Dennis Kubiczek1, Carolin Flaig1, Heinz Raber1, Steffen Dietz1, Ann-Kathrin Kissmann1, Thomas Heerde1, Nicholas Bodenberger2, Andreas Wittgens2, Melaine González-Garcia3, Fan Kang4, Octavio L Franco5,6, Ludger Staendker7, Anselmo J Otero-González3, Paul Walther8, Kay E Gottschalk4, Tanja Weil2, Frank Rosenau1,2.   

Abstract

The pathogenic yeast Candida auris has received increasing attention due to its ability to cause fatal infections, its resistance toward important fungicides, and its ability to persist on surfaces including medical devices in hospitals. To brace health care systems for this considerable risk, alternative therapeutic approaches such as antifungal peptides are urgently needed. In clinical wound care, a significant focus has been directed toward novel surgical (wound) dressings as first defense lines against C. auris. Inspired by Cerberus the Greek mythological "hound of Hades" that prevents the living from entering and the dead from leaving hell, the preparation of a gatekeeper hybrid hydrogel is reported featuring lectin-mediated high-affinity immobilization of C. auris cells from a collagen gel as a model substratum in combination with a release of an antifungal peptide drug to kill the trapped cells. The vision is an efficient and safe two-layer medical composite hydrogel for the treatment of severe wound infections that typically occur in hospitals. Providing this new armament to the repertoire of possibilities for wound care in critical (intensive care) units may open new routes to shield and defend patients from infections and clinical facilities from spreading and invasion of C. auris and probably other fungal pathogens.
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Candida auris; compound encapsulation; drug delivery; intrinsic antimicrobial activity; multicomponent hydrogels

Mesh:

Substances:

Year:  2020        PMID: 32104975     DOI: 10.1002/mabi.202000005

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  7 in total

Review 1.  Emerging and future strategies in the management of recalcitrant Candida auris.

Authors:  Nihal Bandara; Lakshman Samaranayake
Journal:  Med Mycol       Date:  2022-03-17       Impact factor: 4.076

Review 2.  Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.

Authors:  Liliana Fernandes; Rita Ribeiro; Mariana Henriques; Maria Elisa Rodrigues
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-10-06       Impact factor: 5.103

3.  Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro.

Authors:  Dennis Kubiczek; Heinz Raber; Melaine Gonzalez-García; Fidel Morales-Vicente; Ludger Staendker; Anselmo J Otero-Gonzalez; Frank Rosenau
Journal:  Antibiotics (Basel)       Date:  2020-06-27

4.  Antimicrobial Peptides Pom-1 and Pom-2 from Pomacea poeyana Are Active against Candidaauris, C. parapsilosis and C. albicans Biofilms.

Authors:  Heinz Fabian Raber; Jetmira Sejfijaj; Ann-Kathrin Kissmann; Andreas Wittgens; Melaine Gonzalez-Garcia; Annia Alba; Antonio A Vázquez; Fidel E Morales Vicente; Julio Pérez Erviti; Dennis Kubiczek; Anselmo Otero-González; Armando Rodríguez; Ludger Ständker; Frank Rosenau
Journal:  Pathogens       Date:  2021-04-20

5.  BSA Hydrogel Beads Functionalized with a Specific Aptamer Library for Capturing Pseudomonas aeruginosa in Serum and Blood.

Authors:  Markus Krämer; Ann-Kathrin Kissmann; Heinz Fabian Raber; Hu Xing; Patrizia Favella; Ingrid Müller; Barbara Spellerberg; Tanja Weil; Dennis Kubiczek; Susanne Sihler; Ulrich Ziener; Frank Rosenau
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

6.  A Polyclonal SELEX Aptamer Library Allows Differentiation of Candida albicans, C. auris and C. parapsilosis Cells from Human Dermal Fibroblasts.

Authors:  Katharina Kneißle; Markus Krämer; Ann-Kathrin Kissmann; Hu Xing; Franziska Müller; Valerie Amann; Reiner Noschka; Kay-Eberhard Gottschalk; Anil Bozdogan; Jakob Andersson; Tanja Weil; Barbara Spellerberg; Steffen Stenger; Frank Rosenau
Journal:  J Fungi (Basel)       Date:  2022-08-15

Review 7.  Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris.

Authors:  Muriel Billamboz; Zeeshan Fatima; Saif Hameed; Samir Jawhara
Journal:  Microorganisms       Date:  2021-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.